Martin, William P.
Tuohy, Colm
Doody, Alison
Jackson, Sabrina
Canavan, Ronan J.
Slattery, David
Twomey, Patrick J.
McKenna, Malachi J.
le Roux, Carel W.
Docherty, Neil G.
Funding for this research was provided by:
Wellcome Trust (203930/B/16/Z)
Science Foundation Ireland (12/YI/B2480)
Medicinska Forskningsrådet (2015-02733, 2015-02733)
European Foundation for the Study of Diabetes (BI 2017_3, BI 2017_3)
University College Dublin (EKF Diagnostics Ltd.)
Article History
Received: 24 March 2020
Accepted: 5 August 2020
First Online: 9 September 2020
Competing interests
: ClR discloses personal fees outside of the submitted work from Novo Nordisk, GI Dynamics, Eli Lilly, Johnson and Johnson, Sanofi, Aventis, Astra Zeneca, Janssen, Bristol-Myers Squibb and Boehringer-Ingelheim. WPM, CT, AD, SJ, RJC, DS, PJT, MJM, and NGD declare that they have no competing interests.